| 000 | 00837 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514161302.0 | ||
| 264 | 0 | _c20031217 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000073350 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurlanut, M | |
| 245 | 0 | 0 |
_aPharmacology of ifosfamide. _h[electronic resource] |
| 260 |
_bOncology _c2003 |
||
| 300 |
_a2-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadverse effects |
| 700 | 1 | _aFranceschi, L | |
| 773 | 0 |
_tOncology _gvol. 65 Suppl 2 _gp. 2-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000073350 _zAvailable from publisher's website |
| 999 |
_c14327481 _d14327481 |
||